The distressed biotech firm, NovaGen Therapeutics, faced severe monetary difficulties stemming from unsuccessful clinical trials and escalating debt. Their internal team lacked the skill to manage the https://janeqnkt633538.blog5.net/92908081/biotech-cfo-services-a-case-study-in-financial-restructuring